Press Releases
Lilly’s neutralizing antibody bamlanivimab receives FDA emergency use authorization for the treatment of recently diagnosed COVID-19
The U.S. FDA granted Emergency Use Authorization for Eli Lilly and Company's investigational neutralizing antibody bamlanivimab 700 mg. Bamlanivimab is authorized for the treatment...
Drug Research
Transcenta and Merck Announce a Strategic Collaboration at CIIE to Advance Continuous Biomanufacturing
Transcenta, a global biotherapeutics company with fully-integrated capabilities in discovery, development and manufacturing of antibody-based therapeutics, and Merck, a leading science and technology company,...
News
Australia begins production of Oxford Covid-19 vaccine, plans to manufacture 30 million doses
A Covid-19 vaccine co-developed by pharmaceutical company AstraZeneca and the University of Oxford is seen as one of the most promising of all the...
News
Brazil Suspends Trials Of Chinese Covid-19 Vaccine Due To Adverse Incident
Brazil’s health regulator halted clinical trials of the potential coronavirus vaccine CoronaVac, citing an adverse, serious event, according to a statement it posted to...
Clinical Trials
Cancer Treatment Can Be Cloned For COVID-19
As per the recent international study by the scientists from Italy & Australia, Beta-blockers have it in them to be a potential treatment for...
News
A New Senate & its implications on The Pharmaceutical Sector?
The US elections make big news whenever they occur. The fact that who comes to power has a phenomenal effect on all industries, big...
News
AstraZeneca Says Calquence Approved In The EU For CLL
AstraZeneca’s Calquence (acalabrutinib), a next-generation selective Bruton’s tyrosine kinase (BTK) inhibitor, has been approved in the European Union (EU) for the treatment of adult...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read